1 min read

ID: 215160

Discovery Date: 15 June 2022, 06:55:08 UTC

Published Date: NaT

Source: European Clinical Trials Register

Link: https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002977-37

Abstract

EudraCT Number: 2016-002977-37
Sponsor Protocol Number: CRAD001M2X02B
Sponsor Name: Novartis Pharma AG
Start Date: 2017-08-25
Medical condition: Refractory seizures associated with tuberous sclerosis complex
Disease:
Version: 20.0
SOC Term: 10010331 - Congenital, familial and genetic disorders
Classification Code: 10045138
Term: Tuberous sclerosis
Level: PT

Population Age: Children, Adolescents, Under 18, Adults
Gender: Male, Female
Trial Protocol: GB (GB - no longer in EU/EEA), HU (Ongoing), ES (Completed), BE (Completed), FR (Completed), PL (Ongoing), IT (Ongoing)

Noun Phrases in Title

This is an independent project that runs on the good will of volunteers

You can help by spreading the word or by donating what you can to pay for the server costs.